Skip to main content
. 2022 Sep 19;45(10):2336–2341. doi: 10.2337/dc21-2693

Table 1.

Sample characteristics

Full sample (N = 643,287) Only amputation subsample (n = 68,633)
Variable Mean (SD) Range Mean (SD) Range
HCC score 2.4 (1.8) 0–17.9 2.5 (1.9) 0–17.9
Age (years) 74.0 (12.3) 18–114 67.7 (12.4) 21–106
National ADI (weighted) 50.0 (20.2) 0–98.7 52.3 (19.9) 3.0–98.1
No. (%) No. (%)
Sex
 Male 344,555 (53.6) 45,930 (66.9)
 Female 298,732 (46.4) 22,703 (33.1)
Race/ethnicity
 Non-Hispanic/White 515,412 (80.1) 47,460 (69.2)
 Black/AA 87,215 (13.6) 15,272 (22.3)
 Asian 7,139 (1.1) 898 (1.3)
 Hispanic 16,744 (2.6) 2,589 (3.8)
 Native American 6,735 (1.0) 608 (0.9)
 Other 6,517 (1.0) 1,318 (1.9)
 Unknown 3,525 (0.6) 488 (0.7)
Death
 Yes 323,670 (50.3) 28,838 (42.0)
 No 319,617 (49.7) 39,795 (58.0)
Timing of LLA
 LLA <1 year 37,442 (5.8) 42,616 (63.1)
 LLA 1–3 years 17,172 (2.7) 15,065 (22.3)
 LLA ≥3 years 14,019 (2.2) 9,866 (14.6)
 No LLA 574,654 (89.3)
Comorbidities
 Chronic kidney disease 136,107 (21.2) 7,053 (10.3)
 Peripheral vascular disease 185,216 (28.8) 5,285 (7.7)
 Stroke/TIA 506,576 (78.8) 50,803 (74.0)
 Heart disease 101,921 (15.8) 7,547 (11.0)
 Acute myocardial infarction 575,946 (89.5) 57,257 (83.4)